Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.13 HKD | +3.01% | +8.00% | -22.74% |
05-02 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
04-10 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- MarketScreener Editorial Features